- PCYC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $180.7 million.
- PCYC has traded 4,208 shares today.
- PCYC is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PCYC with the Ticky from Trade-Ideas. See the FREE profile for PCYC NOW at Trade-Ideas More details on PCYC: Pharmacyclics, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. PCYC has a PE ratio of 281. Currently there are 2 analysts that rate Pharmacyclics a buy, no analysts rate it a sell, and 9 rate it a hold. The average volume for Pharmacyclics has been 1.5 million shares per day over the past 30 days. Pharmacyclics has a market cap of $20.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.55 and a short float of 5.9% with 3.71 days to cover. Shares are up 111.6% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.